Large-scale testing (Phase 3)UnknownNCT05919407What this trial is testingPyridostigmine and Amifampridine for Myasthenia GravisWho this might be right forMyasthenia Gravis Leiden University Medical Center 24
Not applicableStudy completedNCT06381284What this trial is testingExpediting Myasthenia Gravis (MG) Diagnostic Evaluation: A Novel, Proof-of-Concept for Undiagnosed, Symptomatic Patients That Uses Social Media Targeting and Self-AssessmentWho this might be right forMyasthenia GravisNeuromuscular ManifestationsNeuromuscular Diseases ZS Associates 215
Testing effectiveness (Phase 2)Looking for participantsNCT07284420What this trial is testingADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to EfgartigimodWho this might be right forAChR-Ab Seropositive Generalized Myasthenia GravisMyasthenia GravisMG+3 more argenx 70
Very early researchLooking for participantsNCT07337785What this trial is testingCD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune DiseasesWho this might be right forRelapsing or Refractory Multiple Sclerosis (MS)Myasthenia Gravis (MG)Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)+1 more Daishi Tian 36
Not applicableNot Yet RecruitingNCT07512375What this trial is testingThe Effectiveness of an ETP Programme in Myasthenia Gravis: a Proof-of-concept Study.Who this might be right forMyasthenia Gravis (MG) University Hospital, Grenoble 62
Large-scale testing (Phase 3)Looking for participantsNCT06456580What this trial is testingTelitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)Who this might be right forGeneralized Myasthenia Gravis Vor Biopharma 180
Not applicableStudy completedNCT07472777What this trial is testingLong-term Efficacy of Modified Guilu Erxian Glue for Myasthenia GravisWho this might be right forMyasthenia Gravis (MG) Beijing University of Chinese Medicine 231
Not applicableStudy completedNCT05380128What this trial is testingAssociation Study Between VDR Gene Polymorphisms and Risk and Features of MG in Han Chinese PopulationWho this might be right forMyasthenia Gravis, OcularGene Polymorphism Beijing Tongren Hospital 297
Large-scale testing (Phase 3)Looking for participantsNCT06607627What this trial is testingPK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+ Generalized Myasthenia GravisWho this might be right forGeneralized Myasthenia GravisgMG Alexion Pharmaceuticals, Inc. 12
Large-scale testing (Phase 3)Active Not RecruitingNCT05556096What this trial is testingSafety and Efficacy of ALXN1720 in Adults With Generalized Myasthenia GravisWho this might be right forGeneralized Myasthenia Gravis Alexion Pharmaceuticals, Inc. 261
Testing effectiveness (Phase 2)Study completedNCT01480596What this trial is testingThe Evaluation of Belimumab in Myasthenia Gravis (MG)Who this might be right forMyasthaenia Gravis GlaxoSmithKline 40
Large-scale testing (Phase 3)Study completedNCT05039190What this trial is testingEvaluate the Efficacy and Safety of HBM9161(HL161)Subcutaneous Injection in Patients With Generalized MG PatientsWho this might be right forMyasthenia Gravis Harbour BioMed (Guangzhou) Co. Ltd. 132
Large-scale testing (Phase 3)Looking for participantsNCT07215949What this trial is testingZilucoplan for Severe gMG ExacerbationsWho this might be right forGeneralized Myasthenia Gravis (gMG) Miriam Freimer 15
Large-scale testing (Phase 3)Study completedNCT00294658What this trial is testingThymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone TherapyWho this might be right forMyasthenia Gravis University of Alabama at Birmingham 126
Not applicableNot Yet RecruitingNCT07499323What this trial is testingTalquetamab in Patients With Refractory Generalized Myasthenia GravisWho this might be right forMyasthenia Gravis (MG) First Affiliated Hospital of Chongqing Medical University 2
Testing effectiveness (Phase 2)Active Not RecruitingNCT06359041What this trial is testingRESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia GravisWho this might be right forGeneralized Myasthenia Gravis (gMG) Cabaletta Bio 12
Early research (Phase 1)Study completedNCT05451212What this trial is testingOpen-label Study to Evaluate the Safety of Various Dosing Regimens of MuSK-CAART for MuSK Myasthenia GravisWho this might be right forMuSK Myasthenia Gravis Cabaletta Bio 7
Early research (Phase 1)Ended earlyNCT01828294What this trial is testingSubcutaneous Ig Maintenance Therapy for Myasthenia GravisWho this might be right forMyasthenia Gravis St. Louis University 4
Not applicableLooking for participantsNCT05564936What this trial is testingThe ME&MG Digital Solution for Autonomous Assessment of Myasthenia GravisWho this might be right forMyasthenia Gravis Ad scientiam 144
Large-scale testing (Phase 3)Study completedNCT00309101What this trial is testingAn Open Study for Steroid Resistant, Non-Thymectomized MG PatientsWho this might be right forMyasthenia Gravis Astellas Pharma Inc 11